Record #67289
Temozolomide, Gemcitabine, and Decitabine Hybrid Nanoconjugates: From Design to Proof-of-Concept (PoC) of Synergies toward the Understanding of Drug Impact on Human Glioblastoma Cells
Publisher
Original paper date
Jun 11, 2020
Original DOI
Notes from Retraction Watch
see also: https://pubpeer.com/publications/7B4CD7F058662C1A26513246DF3EE2; see also: https://mis.cnrs.fr/wp-content/uploads/2025/05/Recommandations.pdf
Citation lifecycle
How this paper is being cited
Pre-retraction
11
Same day
0
Post-retraction
12
% post-retraction
52.2%
~5.4 citations/yr before retraction · ~2.8 citations/yr after
— citing papers
Who is still citing this work
Loading…